Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mark J. Weinstein"'
Autor:
Paul D. Mintz, Mark J. Weinstein
Publikováno v:
Rossi's Principles of Transfusion Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85f2d4f2ff655dd178164ef5beaba6e0
https://doi.org/10.1002/9781119013020.ch07
https://doi.org/10.1002/9781119013020.ch07
Publikováno v:
Thrombosis Research. 71:77-88
ATA is a novel anticoagulant polymetic anionic aromatic compound that inhibits von Willebrand factor binding to platelet glycoprotein Ib and thereby prevents ristocetin- and shear stress-induced platelet aggregation. To investigate its mechanism of a
Autor:
Mheir Doursounian, H. MacGregor, Vladimir Birjiniuk, Nancy A. Healey, Shukri F. Khuri, Mark J. Weinstein, Michael A. Zolkewitz, C. Robert Valeri, Joseph Loscalzo
Publikováno v:
The Annals of thoracic surgery. 60(4)
Platelet dysfunction and increased fibrinolysis are the most important etiologic factors in the hemostatic defect observed following the institution of cardiopulmonary bypass. This study examined the effects of heparin per se, administered before the
Publikováno v:
Archives of surgery (Chicago, Ill. : 1960). 128(2)
• Desmopressin acetate (1-deamino-8-D-arginine vasopressin [DDAVP]) improves hemostasis in hemophilia A and von Willebrand's disease and in some platelet disorders. In complex cardiac operations, excluding simple coronary artery bypass graft proced
Autor:
Mark J. Weinstein
Publikováno v:
Desmopressin in Bleeding Disorders ISBN: 9781461362685
The synthetic vasopressin analogue desmopressin acetate (DDAVP) can induce a broad spectrum of physiological reactions that have hematological consequences. These include release of tissue plasminogen activator, depletion of plasminogen activator inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b17f2a729b9c5b5ea76283f16ec52667
https://doi.org/10.1007/978-1-4615-2922-4_20
https://doi.org/10.1007/978-1-4615-2922-4_20
Autor:
Martin Douglas Phillips, Leslie Chute-Rose, Evan Vosburgh, Joel L. Moake, Nancy Turner, Mark J. Weinstein
Publikováno v:
Scopus-Elsevier
Solutions of commercial aurintricarboxylic acid (ATA) inhibit ristocetin- or shear stress-induced, von Willebrand factor (vWF)- mediated platelet aggregation by interacting with vWF and blocking its attachment to platelet membrane glycoprotein Ib. AT
Autor:
Mark J. Weinstein, Daniel Deykin
Publikováno v:
Blood. 53:1095-1105
Both commercial factor VIII concentrate and cryoprecipitate have factor VIII coagulant activity and factor VIII antigen (VIIIR:Ag), but the concentrate lacks the von Willebrand activity (VIIIR:WF) found in the cryoprecipitate. In an effort to find a
Autor:
Noreen M. Colannino, Suchen L. Hong, Mark J. Weinstein, Christine K. Rudy, Joseph H. Troll, Joel L. Moake, John J. Byrnes
Publikováno v:
Blood. 65:1232-1236
Remission plasma samples of some patients with chronic relapsing thrombotic thrombocytopenic purpura (TTP) contain unusually large von Willebrand factor (vWF) multimers similar to those produced by normal human endothelial cells in culture. The infus
Publikováno v:
Blood. 62:1114-1117
We have compared apparent molecular weights of purified factor VIII procoagulant protein (VIII:C) and VIII:C antigen (VIII:CAg) by two different NaDodSO4 gel electrophoretic techniques. In a discontinuous NaDodSO4–7.5% polyacrylamide system, reduce
Autor:
Daniel Deykin, Mark J. Weinstein
Publikováno v:
British Journal of Haematology. 40:617-630
The molecular weight heterogeneity of fibrinogen from the whole plasma of 12 normal and seven cirrhotic individuals was examined by means of a novel two-dimensional sodium dodecyl suphate (SDS) gel electrophoretic technique. Fibrinogen was first sepa